SOMAVAC® presenting at the 13th Annual Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is Texas’ premier life science and health-tech event, taking place on November 7, 2024 to unite industry professionals, investors, and executives.
SOMAVAC® Receives Strong Reception at ASPS Annual Meeting
There was strong recognition at ASPS that seroma mitigation and elimination are essential to transforming outcomes for breast reconstruction patients. Attendees were particularly excited by SOMAVAC’s FDA-cleared technology.
SOMAVAC® CEO Elizabeth Hoff Presents at LSI Europe: Technology Receives Enthusiastic Response
Elizabeth Hoff’s presentation focused on SOMAVAC’s negative pressure wound therapy device, which is designed to address the unmet needs of patients recovering from large flap surgeries, including breast cancer reconstructions.
SOMAVAC® Welcomes Dr. Aldona Spiegel as New Strategic Advisor
We are honored to have Dr. Spiegel on board and look forward to her guidance as we continue to push the boundaries of patient care and innovation. Dr. Spiegel’s passion for advancing medical technology aligns perfectly with SOMAVAC’s commitment to…
‘Smart’ pump latest medical device created in Memphis
The article discusses the innovations made by SOMAVAC in surgical drain technology, led by CEO Esra Roan. SOMAVAC has developed a device that automates the draining and collection of surgical fluids, improving upon the traditional Jackson-Pratt bulb, which has been…
Revolutionary SOMAVAC® SVS in Essential Advantage by Essentially Women
Read about SOMAVAC in the latest issue of Essentially Advantage. Jane Berz, RN, MSN, FNCBC wrote a wonderful article about what SOMAVAC means to the future of drain care. We are so very proud to be part of this amazing…
End of content
End of content
